Supplementary Motor Cortex Revealed as Key Factor in Drug Relapse Risk

Indiana University School of Medicine researchers have uncovered a previously overlooked brain region that could have a significant impact on the likelihood of relapse in individuals with drug use disorders, even after a prolonged withdrawal period. Published in Biological Psychiatry, their study highlights the supplementary motor cortex as a potential critical factor in the risk of relapse, offering a new avenue for therapeutic intervention.

While previous addiction research centered on the medial prefrontal cortex, it had not yielded effective prevention or treatment strategies for drug relapse. Instead, the researchers shifted their focus to the supplementary motor cortex, discovering its pronounced influence on relapse risk. This revelation presents a promising target for the development of therapeutics aimed at relapse prevention.

Through animal models exhibiting cocaine-seeking behaviors, the scientists analyzed excitability levels in the motor cortex after 45 days of withdrawal. They identified increased hyperexcitability during this stage and employed an intervention to mitigate this excitability, effectively suppressing the corresponding brain activity.

Dr. Yao-Ying Ma, co-author on the paper, emphasized that preventing relapse is a major challenge for individuals with addiction. Understanding whether addictive behavior is subconscious or conscious is key to devising more effective treatment and prevention strategies, helping to address relapse and its automatic nature.

Traditionally associated with movement control, the supplementary motor cortex's newfound role in addiction research is both innovative and promising. The team is eager to explore less invasive methods, such as transcranial magnetic stimulation, to leverage this finding and alter the trajectory of addiction treatment. In upcoming studies, the researchers plan to investigate the potential involvement of the supplementary motor cortex in other types of drug use disorders, such as opioid and alcohol use disorders.